Aprameya EngineeringNSE:APRAMEYA -0.54%42 PB Ratio is 4.01 as of Jul. 11, 2026, which is 37% below its 10-year median of 6.38. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 42/100. The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Aprameya Engineering ranks worse than 73.92% on this metric.
Aprameya Engineering Ltd stock PB Ratio (=4.03) is close to 1-year low of 4.03.
The historical rank and industry rank for Aprameya Engineering's PB Ratio or its related term are showing as below:
NSE:APRAMEYA'
s PB Ratio Range Over the Past 10 Years
Min: 2.81 Med: 6.38 Max: 10.22
Current: 4.01
During the past 7 years, Aprameya Engineering's highest PB Ratio was 10.22. The lowest was 2.81. And the median was 6.38.
NSE:APRAMEYA's PB Ratio is ranked worse than 73.92% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs NSE:APRAMEYA: 4.01
During the past 12 months, Aprameya Engineering's average Book Value Per Share Growth Rate was 8.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 51.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 69.60% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Aprameya Engineering was 75.40% per year. The lowest was 51.60% per year. And the median was 69.35% per year.
Back to Basics: PB Ratio
Aprameya Engineering (NSE:APRAMEYA) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Aprameya Engineering PB Ratio Related Terms
Aprameya Engineering PB Ratio Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's PB Ratio distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Aprameya Engineering (NSE:APRAMEYA) has a PB Ratio of 4.01 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Aprameya Engineering and its competitors. This is 37% below median its historical median of 6.38. Over the past decade, Aprameya Engineering's PB Ratio has ranged from 2.81 to 10.22. According to the industry distribution chart, Aprameya Engineering ranks #581 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 73.9%.
Is Aprameya Engineering's PB Ratio too high?
Aprameya Engineering's current PB Ratio of 4.01 is 37% below median its 10-year median of 6.38. Over the past 10 years, this metric has ranged from a low of 2.81 to a high of 10.22. The Medical Devices & Instruments industry median PB Ratio is 2.06. Aprameya Engineering's value of 4.01 is 94.7% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #581 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #581 out of 786 companies for PB Ratio. This places Aprameya Engineering in the lower half of its industry. The industry median PB Ratio is 2.06. Aprameya Engineering's value of 4.01 is 94.7% above this benchmark. Historically, Aprameya Engineering's own PB Ratio has ranged from 2.81 to 10.22 over the past decade. While the company's 10-year median is 6.38 vs. the industry median of 2.06, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current PB Ratio of 4.01 is 94.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current PB Ratio is 4.01, which is 37% below median its own 10-year median of 6.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current PB Ratio of 4.01. The current PB Ratio is 4.01, which is 37% below median its 10-year median of 6.38 and 94.7% above the Medical Devices & Instruments industry median of 2.06. Aprameya Engineering's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current PB Ratio is 4.01 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
42GF Score
Get the complete analysis for NSE:APRAMEYA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 
